Igor Barjaktarević

9.5k total citations · 2 hit papers
130 papers, 4.4k citations indexed

About

Igor Barjaktarević is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Igor Barjaktarević has authored 130 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 27 papers in Physiology and 26 papers in Surgery. Recurrent topics in Igor Barjaktarević's work include Chronic Obstructive Pulmonary Disease (COPD) Research (47 papers), Respiratory Support and Mechanisms (27 papers) and Asthma and respiratory diseases (21 papers). Igor Barjaktarević is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (47 papers), Respiratory Support and Mechanisms (27 papers) and Asthma and respiratory diseases (21 papers). Igor Barjaktarević collaborates with scholars based in United States, Canada and United Kingdom. Igor Barjaktarević's co-authors include Sanja Stanojevic, Teal S. Hallstrand, Margaret Rosenfeld, Bruce Thompson, David A. Kaminsky, Meredith C. McCormack, Martin R. Miller, Brendan Cooper, Graham L. Hall and Maureen P. Swanney and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Igor Barjaktarević

119 papers receiving 4.3k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

2019 2.3k citations Brian L. Graham, Irene Steenbruggen et al. American Journal of Respiratory and Critical Care Medicine profile →
ERS/ATS technical standard on interpretive strategies for routine lung function tests

2021 665 citations Sanja Stanojevic, David A. Kaminsky et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Barjaktarević United States	23	2.9k	1.3k	542	424	347	130	4.4k
Brendan Cooper United Kingdom	27	4.5k 1.5×	2.1k 1.6×	488 0.9×	456 1.1×	677 2.0×	91	6.3k
Νikolaos Koulouris Greece	38	2.9k 1.0×	1.8k 1.3×	261 0.5×	373 0.9×	224 0.6×	179	4.4k
Fabiano Di Marco Italy	34	2.8k 1.0×	1.6k 1.2×	308 0.6×	360 0.8×	217 0.6×	191	4.2k
Agnaldo José Lopes Brazil	27	1.9k 0.7×	915 0.7×	277 0.5×	249 0.6×	196 0.6×	289	3.3k
Paolo Palange Italy	37	3.4k 1.2×	1.3k 1.0×	284 0.5×	1.1k 2.6×	159 0.5×	185	5.0k
Brian L. Graham Canada	23	3.7k 1.3×	1.5k 1.1×	320 0.6×	347 0.8×	489 1.4×	61	5.0k
Maureen P. Swanney New Zealand	20	2.4k 0.8×	1.1k 0.9×	228 0.4×	204 0.5×	285 0.8×	36	3.4k
Armando Aguirre‐Jaime Spain	32	2.9k 1.0×	1.2k 0.9×	393 0.7×	390 0.9×	75 0.2×	119	4.5k
Bruce H. Culver United States	15	4.9k 1.7×	2.3k 1.8×	474 0.9×	344 0.8×	234 0.7×	27	6.1k
Raffaello Pellegrino Italy	23	6.7k 2.3×	3.5k 2.7×	678 1.3×	464 1.1×	222 0.6×	79	8.2k

Countries citing papers authored by Igor Barjaktarević

Since Specialization

Citations

This map shows the geographic impact of Igor Barjaktarević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Barjaktarević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Barjaktarević more than expected).

Fields of papers citing papers by Igor Barjaktarević

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Barjaktarević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Barjaktarević. The network helps show where Igor Barjaktarević may publish in the future.

Co-authorship network of co-authors of Igor Barjaktarević

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Barjaktarević. A scholar is included among the top collaborators of Igor Barjaktarević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Barjaktarević. Igor Barjaktarević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tashkin, Donald P., et al.. (2024). Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 37(4). 189–201. 5 indexed citations

Andersen, T I, Seon Cheol Park, Fereidoun Abtin, et al.. (2024). Association of bronchial disease on CT imaging and clinical definitions of chronic bronchitis in a single-center COPD phenotyping study. Respiratory Medicine. 231. 107733–107733. 1 indexed citations

Tashkin, Donald P., et al.. (2024). Impact of Marijuana Use on Lung Health. Seminars in Respiratory and Critical Care Medicine. 45(5). 548–559.

Ryu, Min Hyung, Jeong H. Yun, Jarrett D. Morrow, et al.. (2023). Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations. American Journal of Respiratory and Critical Care Medicine. 208(3). 247–255. 13 indexed citations

Barjaktarević, Igor, et al.. (2023). Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Significantly Reduces Annualized Exacerbations and Delays the Time to First Exacerbation in COPD: Pooled Sub-Group Analyses of Enhance-1 and Enhance-2 Phase 3 Trials. A5008–A5008. 2 indexed citations

Lee, J.S., Andrea Oh, Jonathan Goldin, et al.. (2023). COMPUTER-ASSISTED QUANTITATIVE IMAGE ANALYSIS FOR IDENTIFICATION OF PULMONARY FIBROSIS AND EMPHYSEMA: PATHWAY TO CHARACTERIZING CPFE. CHEST Journal. 164(4). A4011–A4012. 1 indexed citations

Barjaktarević, Igor, et al.. (2023). Ensifentrine Reduced Healthcare Resource Utilization in Subjects With COPD: Results From Enhance-2, a Phase 3 Trial of Ensifentrine, a Dual PDE3/4 Inhibitor. A2839–A2839. 1 indexed citations

Wong, K.P., Sindy H. Wei, Oscar Estrada, et al.. (2023). Integration and evaluation of chest X-ray artificial intelligence in clinical practice. Journal of Medical Imaging. 10(5). 51805–51805. 6 indexed citations

Park, Seon Cheol, Narongkorn Saiphoklang, Jonathan E. Phillips, et al.. (2023). Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD. International Journal of COPD. Volume 18. 1475–1486. 3 indexed citations

10.

Yan, Peter, Daniela Markovic, Russell G. Buhr, et al.. (2023). Eosinophil recovery in hospitalized COVID-19 patients is associated with lower rates of ICU admission and in-hospital mortality: An observational cohort analysis. Respiratory Medicine and Research. 84. 101031–101031. 3 indexed citations

11.

Buhr, Russell G., Igor Barjaktarević, P. Miguel Quibrera, et al.. (2022). Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. American Journal of Respiratory and Critical Care Medicine. 206(5). 554–562. 22 indexed citations

12.

Yan, Peter, Daniela Markovic, Russell G. Buhr, et al.. (2022). Chronic Obstructive Pulmonary Disease is Not Associated with In-Hospital Mortality in COVID-19: An Observational Cohort Analysis. International Journal of COPD. Volume 17. 3111–3121. 5 indexed citations

13.

Park, Seon‐Cheol, Narongkorn Saiphoklang, Jonathan E. Phillips, et al.. (2022). Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity. Sensors. 22(6). 2264–2264. 11 indexed citations

14.

Shaikh, Faisal M., Jon‐Émile S. Kenny, Daniela Markovic, et al.. (2022). Measuring the accuracy of cardiac output using POCUS: the introduction of artificial intelligence into routine care. The Ultrasound Journal. 14(1). 47–47. 20 indexed citations

15.

Drummond, Michael, Andrew Edmonds, Catalina Ramirez, et al.. (2022). Association Between HIV and Prevalence and Manifestations of Asthma: Analysis of the Multicenter AIDS Cohort Study and Women's Interagency HIV Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(5). 419–428. 1 indexed citations

16.

Stanojevic, Sanja, David A. Kaminsky, Martin R. Miller, et al.. (2021). ERS/ATS technical standard on interpretive strategies for routine lung function tests. European Respiratory Journal. 60(1). 2101499–2101499. 665 indexed citations breakdown →

17.

Hoffman, Eric A., Jessica C. Sieren, Alejandro P. Comellas, et al.. (2020). A CT-Based Automated Algorithm for Airway Segmentation Using Freeze-and-Grow Propagation and Deep Learning. IEEE Transactions on Medical Imaging. 40(1). 405–418. 34 indexed citations

18.

Graham, Brian L., Irene Steenbruggen, Martin R. Miller, et al.. (2019). Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. American Journal of Respiratory and Critical Care Medicine. 200(8). e70–e88. 2305 indexed citations breakdown →

19.

Kessler, Ross, et al.. (2017). Critical care ultrasound: A national survey across specialties. Journal of Clinical Ultrasound. 46(3). 167–177. 28 indexed citations

20.

Barjaktarević, Igor, et al.. (2006). The Role of Gamma Interferon-Inducible Lysosomal Thiol Reductase (GILT) in T-cell Activation. The FASEB Journal. 20(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact